Logo image
DNA markers in molecular diagnostics for hepatocellular carcinoma
Journal article   Open access   Peer reviewed

DNA markers in molecular diagnostics for hepatocellular carcinoma

Ying-Hsiu Su, Selena Y. Lin, Wei Song and Surbhi Jain
Expert review of molecular diagnostics, v 14(7), pp 803-817
01 Sep 2014
PMID: 25098554
url
https://europepmc.org/articles/pmc4480673View
Accepted (AM)Open Access (License Unspecified) Open

Abstract

Life Sciences & Biomedicine Science & Technology Pathology
Hepatocellular carcinoma (HCC) is the one of the leading causes of cancer mortality in the world, mainly due to the difficulty of early detection and limited therapeutic options. The implementation of HCC surveillance programs in well-defined, high-risk populations were only able to detect about 40-50% of HCC at curative stages (Barcelona Clinic Liver Cancer stages 0 & 1) due to the low sensitivities of the current screening methods. The advance of sequencing technologies has identified numerous modifications as potential candidate DNA markers for diagnosis/surveillance. Here we aim to provide an overview of the DNA alterations that result in activation of cancer pathways known to potentially drive HCC carcinogenesis and to summarize performance characteristics of each DNA marker in the periphery (blood or urine) for HCC screening.

Metrics

9 Record Views
21 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Pathology
Logo image